X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (422) 422
oncology (264) 264
female (230) 230
male (209) 209
adult (168) 168
mutation (160) 160
middle aged (152) 152
pathology (152) 152
cancer (146) 146
aged (139) 139
tumors (115) 115
lung neoplasms - genetics (112) 112
adenocarcinoma - genetics (75) 75
adolescent (70) 70
aged, 80 and over (69) 69
genetic aspects (69) 69
immunohistochemistry (68) 68
prognosis (67) 67
expression (65) 65
gefitinib (64) 64
genomics (62) 62
child (59) 59
lung neoplasms - drug therapy (59) 59
oncogene proteins, fusion - genetics (57) 57
animals (55) 55
lung neoplasms - pathology (55) 55
mutations (54) 54
translocation, genetic (53) 53
lung cancer (52) 52
research (51) 51
biomarkers, tumor - genetics (48) 48
gene (48) 48
proto-oncogene proteins - genetics (47) 47
cell line, tumor (45) 45
genes (45) 45
neoplasms - genetics (43) 43
gene expression regulation, neoplastic (42) 42
receptor, epidermal growth factor - genetics (42) 42
adenocarcinoma (40) 40
cell biology (39) 39
gene rearrangement (37) 37
reverse transcriptase polymerase chain reaction (37) 37
antineoplastic agents - therapeutic use (36) 36
genetics & heredity (36) 36
surgery (36) 36
egfr (35) 35
gene expression (35) 35
mice (34) 34
ras proteins - genetics (34) 34
translocation (34) 34
chemotherapy (33) 33
dna mutational analysis (33) 33
in situ hybridization, fluorescence (33) 33
phenotype (33) 33
transcription factors - genetics (33) 33
adenocarcinoma - pathology (32) 32
erbb receptors - genetics (32) 32
respiratory system (32) 32
sarcoma (32) 32
base sequence (31) 31
erlotinib (31) 31
molecular sequence data (31) 31
protein kinase inhibitors - therapeutic use (31) 31
analysis (30) 30
gene mutations (30) 30
genomes (30) 30
neoplasms (30) 30
proto-oncogene proteins p21 (30) 30
adenocarcinoma - drug therapy (29) 29
gene amplification (29) 29
gene-mutations (29) 29
genetic predisposition to disease (29) 29
multidisciplinary sciences (29) 29
adenocarcinoma of lung (28) 28
carcinoma (28) 28
carcinoma, non-small-cell lung - genetics (28) 28
deoxyribonucleic acid--dna (28) 28
gene expression profiling (28) 28
mutation - genetics (28) 28
proteins (28) 28
treatment outcome (28) 28
young adult (28) 28
fusion (27) 27
health aspects (27) 27
diagnosis (26) 26
polymerase chain reaction (26) 26
amplification (25) 25
carcinoma, non-small-cell lung - drug therapy (25) 25
child, preschool (25) 25
predictive value of tests (25) 25
acquired-resistance (24) 24
biochemistry & molecular biology (24) 24
care and treatment (24) 24
dna methylation (24) 24
dna-binding proteins - genetics (24) 24
exons (24) 24
identification (24) 24
kras (24) 24
metastasis (24) 24
sensitivity (24) 24
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature medicine, ISSN 1078-8956, 2014, Volume 20, Issue 9, pp. 1027 - 1034
Journal Article
Acta neuropathologica, ISSN 1432-0533, 2016, Volume 133, Issue 3, pp. 417 - 429
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2011, Volume 29, Issue 15, pp. 2046 - 2051
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 8, pp. 731 - 739
Journal Article
Nature genetics, ISSN 1546-1718, 2012, Volume 44, Issue 8, pp. 852 - 860
Human non-small cell lung cancers (NSCLCs) with activating mutations in EGFR frequently respond to treatment with EGFRtargeted tyrosine kinase inhibitors... 
GEFITINIB | RECEPTOR TYROSINE KINASES | MET AMPLIFICATION | GROWTH | GENETICS & HEREDITY | ACQUIRED-RESISTANCE | MUTATIONS | NF-KAPPA-B | TUMORS | MUTANT EGFR | ERLOTINIB | Erlotinib Hydrochloride | Proto-Oncogene Proteins c-met - metabolism | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Humans | Lung Neoplasms - metabolism | Middle Aged | Lung Neoplasms - pathology | Male | Intercellular Signaling Peptides and Proteins - metabolism | Epithelial-Mesenchymal Transition | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Intercellular Signaling Peptides and Proteins - genetics | Proto-Oncogene Proteins - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Proto-Oncogene Proteins c-met - genetics | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Receptor Protein-Tyrosine Kinases - genetics | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Enzyme Activation | Mutation | Quinazolines - pharmacology | Erlotinib | Physiological aspects | Genetic aspects | Research | Lung cancer, Non-small cell | Drug therapy | Health aspects | Protein kinases | Studies | Medical research | Rodents | Lung cancer | Genomics | Kinases | Gene expression | Acquisitions & mergers | Tumors
Journal Article